Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 2:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2401–2424 of 145,407 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Cystic Fibrosis, Pediatrics
Interventions: Sputum; Biological
Lead sponsor: University of Miami; Other
Eligibility: Up to 18 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Weight Loss, Bone Density, Obesity and Overweight
Interventions: Peanut Snack Experimental, Nut-free Snack; Dietary Supplement
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 50 Years to 75 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Venous Thrombosis, Atrial Fibrillation, Myocardial Infarction
Interventions: Genomics; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Study Adherence, Depressive Disorder
Interventions: Video-Chat Psychotherapy (VCP), Message-Based Psychotherapy (MBP), Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy, Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy, High Monetary Incentive (HMI), Low Monetary and Alternative Incentive (LMAI); Behavioral
Lead sponsor: Talkspace; Industry
Eligibility: 18 Years and older
Enrollment: 1,184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Cataract
Interventions: Intraocular lens; Device
Lead sponsor: George O. Waring IV; Other
Eligibility: 40 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Knee Osteoarthritis
Interventions: Keeogo; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Vestibular Disorder
Interventions: EquiCue (Intraoral Electronic Balance Aid); Device
Lead sponsor: Innervo Technology LLC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 2
States / cities: Columbia, Missouri • Independence, Missouri

Conditions: Melanoma (Skin)
Interventions: QS21, gp100 antigen, incomplete Freund's adjuvant, sargramostim, tyrosinase peptide; Biological
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2001
U.S. locations: 1
States / cities: New York, New York

Conditions: Deglutition Disorders, Respiratory Aspiration
Interventions: Cold Liquid Barium; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 36 Weeks to 43 Weeks
Enrollment: 4,043 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Brain Injuries
Interventions: CDP-Choline, Placebo; Drug
Lead sponsor: Patricia M. Arenth; Other
Eligibility: 18 Years to 55 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Venous Thromboembolism, Metastatic Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma
Interventions: Kinisoquin™, Placebo; Drug
Lead sponsor: Quercis Pharma AG; Industry
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: Ventura, California • Miami Lakes, Florida • Boston, Massachusetts

Conditions: Anemia
Interventions: Venofer; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 12 Years to 16 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Prostatic Neoplasms, Prostate Cancer
Interventions: Abiraterone acetate, Prednisone; Drug
Lead sponsor: Cougar Biotechnology, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 12
States / cities: Los Angeles, California • San Francisco, California • Baltimore, Maryland + 2 more

Conditions: Alzheimer Dementia
Interventions: Allopregnanolone; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 55 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Rheumatoid Arthritis
Interventions: PDA001, Vehicle Controlled Placebo; Biological · Drug
Lead sponsor: Celularity Incorporated; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 16
States / cities: Anniston, Alabama • Arcadia, California • Los Angeles, California + 12 more

Conditions: Pancreatic Cancer
Interventions: protein analysis, laboratory biomarker analysis; Genetic · Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: Not listed
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 3
States / cities: Nashville, Tennessee

Conditions: Refractory B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia
Interventions: UCART19; Biological
Lead sponsor: Institut de Recherches Internationales Servier; Other
Eligibility: Up to 17 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Los Angeles, California • Philadelphia, Pennsylvania • Dallas, Texas

Conditions: Heart Failure
Interventions: Telemonitoring, Flexible Diuretic Regimen; Device · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Epilepsy (Treatment Refractory)
Interventions: Trigeminal nerve stimulation; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Osteoarthritis, Knee
Interventions: FX006 32 mg; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 40 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 9
States / cities: El Cajon, California • La Mesa, California • Pomona, California + 5 more

Conditions: HIV Infections, Dyslipidemia, Endothelial Dysfunction
Interventions: extended release niacin; Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Enlarged Prostate (BPH), Enlarged Prostate With Lower Urinary Tract Symptoms
Interventions: Ejaculatory-sparing (ES-sparing) HoLEP; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Muscle Damage, Muscle Inflammation
Interventions: Lovaza (omega-3-acid ethyl esters), Wheat Germ Oil; Drug
Lead sponsor: Western Michigan University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Kalamazoo, Michigan

Conditions: Cocaine Use Disorder
Interventions: Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable matched to XR-NTX, Placebo (PLB) Injectable matched to XR-BUP; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 12
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 8 more

Search by objective public record fields.

A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida

Metabolic Health, Bones and Nuts During Weight Loss in Adults

Personalized Warfarin Dosing by Genomics and Computational Intelligence

Message-Based Psychotherapy and Digital Treatment Sequences for Depression

Clinical Outcomes Following Implantation of Tecnis Synergy and Symfony Intraocular Lens

A Powered Exoskeleton for Veterans With Knee OA

Testing an Intraoral Electronic Balance Aid for Vestibular Imbalance

Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma

Cold Liquids Fed to Preterm Infants: Efficacy and Safety After 10 Minutes of Exposure

CDP-Choline and Working Memory After TBI: A Neuroimaging Study

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis

Studying Biomarkers in Patients With Pancreatic Cancer

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project

Trigeminal Nerve Stimulation of the Treatment of Epilepsy

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels

Ejaculatory-Sparing HoLEP vs Standard HoLEP

The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)